Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical and Molecular Allergy
Published in: Clinical and Molecular Allergy 1/2012

Open Access 01-12-2012 | Research

Clara cell protein in nasal lavage fluid and nasal nitric oxide - biomarkers with anti-inflammatory properties in allergic rhinitis

Authors: Kristina Irander, Jörgen P Palm, Magnus P Borres, Bijar Ghafouri

Published in: Clinical and Molecular Allergy | Issue 1/2012

Login to get access

Abstract

Background

Clara cell protein (CC16) is ascribed a protective and anti-inflammatory role in airway inflammation. Lower levels have been observed in asthmatic subjects as well as in subjects with intermittent allergic rhinitis than in healthy controls. Nasal nitric oxide (nNO) is present in high concentrations in the upper airways, and considered a biomarker with beneficial effects, due to inhibition of bacteria and viruses along with stimulation of ciliary motility. The aim of this study was to evaluate the presumed anti-inflammatory effects of nasal CC16 and nNO in subjects with allergic rhinitis.

Methods

The levels of CC16 in nasal lavage fluids, achieved from subjects with persistent allergic rhinitis (n = 13), intermittent allergic rhinitis in an allergen free interval (n = 5) and healthy controls (n = 7), were analyzed by Western blot. The levels of nNO were measured by the subtraction method using NIOX®. The occurrences of effector cells in allergic inflammation, i.e. metachromatic cells (MC, mast cells and basophiles) and eosinophils (Eos) were analyzed by light microscopy in samples achieved by nasal brushing.

Results

The levels of CC16 correlated with nNO levels (r2 = 0.37; p = 0.02) in allergic subjects.
The levels of both biomarkers showed inverse relationships with MC occurrence, as higher levels of CC16 (p = 0.03) and nNO (p = 0.05) were found in allergic subjects with no demonstrable MC compared to the levels in subjects with demonstrable MC. Similar relationships, but not reaching significance, were observed between the CC16 and nNO levels and Eos occurrence. The levels of CC16 and nNO did not differ between the allergic and the control groups.

Conclusions

The correlation between nasal CC16 and nNO levels in patients with allergic rhinitis, along with an inverse relationship between their levels and the occurrences of MC in allergic inflammation, may indicate that both biomarkers have anti-inflammatory effects by suppression of cell recruitment. The mechanisms behind these observations warrant further analyses.
Appendix
Available only for authorised users
Literature
1.
Bernard A, Lauwerys R: Low-molecular-weight proteins as markers of organ toxicity with special reference to Clara cell protein. Toxicol Lett. 1995, 77: 145-151. 10.1016/0378-4274(95)03284-3CrossRefPubMed
2.
Broeckaert F, Bernard A: Clara cell secretory protein (CC16): characteristics and perspectives as lung peripheral biomarker. Clin Exp Allergy. 2000, 30: 469-475. 10.1046/j.1365-2222.2000.00760.xCrossRefPubMed
3.
Lakind JS, Holgate ST, Ownby DR, Mansur AH, Helms PJ, Pyatt D, Hays SM: A critical review of the use of Clara cell secretory protein (CC16) as a biomaker of acute or chronic pulmonary effects. Biomarkers. 2007, 12: 445-467. 10.1080/13547500701359327CrossRefPubMed
4.
Lindahl M, Svartz J, Tagesson C: Demonstration of different forms of the anti-inflammatory proteins lipocortin-1 and Clara cell protein-16 in human nasal and bronchoalveolar lavage fluids. Electrophoresis. 1999, 20: 881-890. 10.1002/(SICI)1522-2683(19990101)20:4/5<881::AID-ELPS881>3.0.CO;2-6CrossRefPubMed
5.
Lindahl M, Irander K, Tagesson C, Ståhlbom B: Nasal lavage fluid and proteomics as means to identify the effects of the irritating epoxy chemical dimethylbenzylamine. Biomarkers. 2004, 9: 56-70. 10.1080/13547500410001662005CrossRefPubMed
6.
Gomes EC, Stone V, Florida-James G: Impact of heat and pollution on oxidative stress and CC16 secretion after 8 km run. Eur J Appl Physiol. 2011, 111: 2089-2097. 10.1007/s00421-011-1839-xCrossRefPubMed
7.
Johansson S, Keen C, Ståhl A, Wennergren G, Benson M: Low levels of CC16 in nasal fluid of children with birch pollen-induced rhinitis. Allergy. 2005, 60: 638-642. 10.1111/j.1398-9995.2005.00775.xCrossRefPubMed
8.
Benson M, Jansson L, Adner M, Luts A, Uddman R, Cardell LO: Gene profiling reveals decreased expression of uteroglobin and other anti-inflammatory genes in nasal fluid cells from patients with intermittent allergic rhinitis. Clin Exp Allergy. 2005, 35: 473-478. 10.1111/j.1365-2222.2005.02206.xCrossRefPubMed
9.
Benson M, Fransson M, Martinsson T, Naluai ÅT, Uddman R, Cardell LO: Inverse relation between nasal fluid Clara Cell Protein 16 levels and symptoms and signs of rhinitis in allergen-challenged patients with intermittent allergic rhinitis. Allergy. 2007, 62: 178-183.CrossRefPubMed
10.
Lundberg JO: Nitric oxide and the paranasal sinuses. Anat Rec. 2008, 291: 1479-1484. 10.1002/ar.20782.CrossRef
11.
Borres MP, Irander K, Björkstén B: Nasal metachromatic cells in infants in relation to allergic disease and family history of atopy. Pediatr Allergy Immunol. 1991, 4: 184-189.CrossRef
12.
Borres MP, Irander K, Björkstén B: Nasal metachromatic cells in infancy in relation to the appearance of atopic disease during the first 6 years of life. Allergy. 1997, 52: 770-774. 10.1111/j.1398-9995.1997.tb01237.xCrossRefPubMed
13.
Irander K, Borres MP: An 18-year follow-up of allergy development related to nasal metachromatic cell findings during infancy. Allergol Int. 2010, 59: 193-200. 10.2332/allergolint.09-OA-0132CrossRefPubMed
14.
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976, 72: 248-254. 10.1016/0003-2697(76)90527-3CrossRefPubMed
15.
, : ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005, 171: 912-930.CrossRef
16.
Palm JP, Graf P, Lundberg JON, Alving K: Characterization of exhaled nitric oxide: introducing a new reproducible method for nasal nitric oxide measurements. Eur Respir J. 2000, 16: 236-241. 10.1034/j.1399-3003.2000.16b09.xCrossRefPubMed
17.
Zetterquist W, Pedroletti C, Lundberg JON, Alving K: Salivary contribution to exhaled nitric oxide. Eur Resp J. 1999, 13: 327-333. 10.1034/j.1399-3003.1999.13b18.x.CrossRef
18.
Shijubo N, Itoh Y, Yamaguchi T, Imada A, Hirasawa M, Yamada T, Kawai T, Abe S: Clara cell protein-positive epithelial cells are reduced in small airways of asthmatics. Am J Respir Crit Care Med. 1999, 160: 930-933.CrossRefPubMed
19.
de Burbure C, Pignatti P, Corradi M, Malerba M, Clippe A, Dumont X, Moscato G, Mutti A, Bernard A: Uteroglobin-related protein 1 and Clara cell protein in induced sputum of patients with asthma and rhinitis. Chest. 2007, 131: 172-179. 10.1378/chest.06-0835CrossRefPubMed
20.
Turner S: The role of exhaled nitric oxide in the diagnosis, management and treatment of asthma. Mini Rev Med Chem. 2007, 7: 539-542.PubMed
21.
Barnes PJ, Dweik RA, Gelb AF, Gibson PG, George SC, Grasemann H, Pavord ID, Ratjen F, Silkoff PE, Taylor DR, Zamel N: Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest. 2010, 138: 682-692. 10.1378/chest.09-2090CrossRefPubMed
22.
Porsbjerg C, Lund TK, Pedersen L, Backer V: Inflammatory subtypes in asthma are related to airway hyperresponsiveness to mannitol and exhaled NO. J Asthma. 2009, 46: 606-612. 10.1080/02770900903015654CrossRefPubMed
23.
Maniscalco M, Sofia M, Pelaia G: Nitric oxide in upper airways inflammatory diseases. Inflamm Res. 2007, 56: 58-69. 10.1007/s00011-006-6111-1CrossRefPubMed
24.
Larsson AK, Bäck M, Hjoberg J, Dahlén SE: Inhibition of nitric-oxide synthase enhances antigen-induced contractions and increases release of cysteinyl-leucotrienes in guinea pig lung parenchyma: nitric oxide as a protective factor. J Pharmacol Exp Ther. 2005, 315: 458-465. 10.1124/jpet.105.086694CrossRefPubMed
25.
Larsson AK, Bäck M, Lundberg JO, Dahlén SE: Specific mediator inhibition by the NO donors SNP and NCX 2057 in the peripheral lung: implications for allergen-induced bronchoconstriction. Respir Res. 2009, 10: 46. 10.1186/1465-9921-10-46PubMedCentralCrossRefPubMed
26.
Coleman JW: Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin Exp Immunol. 2002, 129: 4-10. 10.1046/j.1365-2249.2002.01918.xPubMedCentralCrossRefPubMed
27.
Lundberg JO: Airborne nitric oxide: inflammatory marker and aerocrine messenger in man. Acta Physiol Scand Suppl. 1996, 633: 1-27.PubMed
28.
Maniscalco M, Sofia M, Carratù L, Higenbottam T: Effect of nitric oxide inhibition on nasal airway resistance after nasal allergen challenge in allergic rhinitis. Eur J Clin Invest. 2001, 31: 462-466. 10.1046/j.1365-2362.2001.00825.xCrossRefPubMed
29.
Moody A, Fergusson W, Wells A, Bartley J, Kolbe J: Nasal levels of nitric oxide as an outcome variable in allergic upper respiratory tract disease: Influence of atopy and hayfever on nNO. Am J Rhinol. 2006, 20: 425-429. 10.2500/ajr.2006.20.2921CrossRefPubMed
30.
Palm JP, Alving K, Lundberg JO: Characterization of airway nitric oxide in allergic rhinitis: the effect of intranasal administration of L-NAME. Allergy. 2003, 58: 885-892. 10.1034/j.1398-9995.2003.00098.xCrossRefPubMed
Metadata
Title
Clara cell protein in nasal lavage fluid and nasal nitric oxide - biomarkers with anti-inflammatory properties in allergic rhinitis
Authors
Kristina Irander
Jörgen P Palm
Magnus P Borres
Bijar Ghafouri
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Clinical and Molecular Allergy / Issue 1/2012
Electronic ISSN: 1476-7961
DOI
https://doi.org/10.1186/1476-7961-10-4

Other articles of this Issue 1/2012

Clinical and Molecular Allergy 1/2012 Go to the issue

Research

Enhanced effects of cigarette smoke extract on inflammatory cytokine expression in IL-1β-activated human mast cells were inhibited by Baicalein via regulation of the NF-κB pathway

Review

Anaphylactic Reactions to Oligosaccharides in Red Meat: a Syndrome in Evolution

Research

The usefulness of casein-specific IgE and IgG4 antibodies in cow's milk allergic children

Research

Defining the molecular role of gp91phox in the immune manifestation of acute allergic asthma using a preclinical murine model

Research

IL-3 and TNFα increase Thymic Stromal Lymphopoietin Receptor (TSLPR) expression on eosinophils and enhance TSLP-stimulated degranulation

Research

Specific IgE response to different grass pollen allergen components in children undergoing sublingual immunotherapy